Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis.

Biochem Biophys Res Commun

Third Department of Internal Medicine, Yamanashi Medical University, Tamaho, Yamanashi, 409-3898, Japan.

Published: October 2000

Aldose reductase (AKR1B1) is the first enzyme in the polyol pathway through which glucose is converted to sorbitol, and has been implicated in the etiology of diabetic complications. However, its physiological role is still not well understood. In the kidney, AKR1B1 is quite abundant in the collecting tubule cells and thought to provide protection against hypertonic environment. We report here that the mice lacking AKR1B1 showed hypercalciuria, hypercalcemia, hypermagnesemia, and reduced ability to concentrate urine, suggesting a new physiological role of AKR1B1 in divalent cation homeostasis.

Download full-text PDF

Source
http://dx.doi.org/10.1006/bbrc.2000.3648DOI Listing

Publication Analysis

Top Keywords

aldose reductase
8
divalent cation
8
cation homeostasis
8
physiological role
8
akr1b1
5
disruption aldose
4
reductase gene
4
gene akr1b1
4
akr1b1 defect
4
defect urinary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!